US equities
|
MU
$904.90
▲+0.00%
SNDK
$1,371.12
▲+0.00%
NVDA
$217.09
▲+0.00%
SPCX
$147.96
▲+0.00%
AAPL
$342.94
▲+0.00%
TSLA
$368.06
▲+0.00%
SKHY
$142.87
▲+0.00%
INTC
$92.03
▲+0.00%
MU
$904.90
▲+0.00%
SNDK
$1,371.12
▲+0.00%
NVDA
$217.09
▲+0.00%
SPCX
$147.96
▲+0.00%
AAPL
$342.94
▲+0.00%
TSLA
$368.06
▲+0.00%
SKHY
$142.87
▲+0.00%
INTC
$92.03
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Articles published by Precigen, Inc.
Precigen's Strong Second Quarter Signals Significant Growth, Validates AdenoVerse Platform; PRGN-2009 Advances in HPV-Driven Cancers
August 25, 2026
From
Precigen, Inc.
Via
ACCESS Newswire
Tickers
PGEN